Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth A Katz

Showing results (1-10 of 96) with videos related to

Pageof 10
Sort By:
The New England Journal of Medicine|December 3, 2010
Health hazards of "don't ask, don't tell"Kenneth A Katz
JAMA Dermatology|June 14, 2018
Problematic End Points in a Trial of Topical Fluorouracil, 5%, for Chemoprevention of Keratinocyte CarcinomaKenneth A Katz
The Journal of Investigative Dermatology|February 17, 2006
Population-based sciences: Freedberg and the "burden of skin diseases"Kenneth A Katz
Dermatology Online Journal|November 5, 2003
Disseminated cutaneous granulomatous eruption occurring in the setting of myelodysplasiaKenneth A Katz
Journal of the American Academy of Dermatology|August 23, 2005
Psoriasis Area and Severity Index 50 as an endpoint in psoriasis trials: an unconvincing proposalKenneth A Katz
Archives of Dermatology|June 21, 2006
The (relative) risks of using odds ratiosKenneth A Katz
JAMA Dermatology|October 20, 2017
Industry Influence in Dermatology Clinical Practice Guideline DevelopmentKenneth A Katz
Journal of the American Academy of Dermatology|October 15, 2020
Unethical use of imiquimod as a comparator group in a randomized clinical trial of children with molluscum contagiosumKenneth A Katz
Pediatric Dermatology|September 19, 2019
Quality care for lesbian, gay, bisexual, transgender, and queer patients in pediatric dermatologyKenneth A Katz
JAMA Dermatology|September 8, 2018
Congenital Syphilis-Still a Shadow on the LandKenneth A Katz
Pageof 10

Showing results (1-10 of 96) with videos related to

Sort By:
Pageof 10
The New England Journal of Medicine|December 3, 2010
Health hazards of "don't ask, don't tell"Kenneth A Katz
JAMA Dermatology|June 14, 2018
Problematic End Points in a Trial of Topical Fluorouracil, 5%, for Chemoprevention of Keratinocyte CarcinomaKenneth A Katz
The Journal of Investigative Dermatology|February 17, 2006
Population-based sciences: Freedberg and the "burden of skin diseases"Kenneth A Katz
Dermatology Online Journal|November 5, 2003
Disseminated cutaneous granulomatous eruption occurring in the setting of myelodysplasiaKenneth A Katz
Journal of the American Academy of Dermatology|August 23, 2005
Psoriasis Area and Severity Index 50 as an endpoint in psoriasis trials: an unconvincing proposalKenneth A Katz
Archives of Dermatology|June 21, 2006
The (relative) risks of using odds ratiosKenneth A Katz
JAMA Dermatology|October 20, 2017
Industry Influence in Dermatology Clinical Practice Guideline DevelopmentKenneth A Katz
Journal of the American Academy of Dermatology|October 15, 2020
Unethical use of imiquimod as a comparator group in a randomized clinical trial of children with molluscum contagiosumKenneth A Katz
Pediatric Dermatology|September 19, 2019
Quality care for lesbian, gay, bisexual, transgender, and queer patients in pediatric dermatologyKenneth A Katz
JAMA Dermatology|September 8, 2018
Congenital Syphilis-Still a Shadow on the LandKenneth A Katz
Pageof 10